Metabolic abnormalities and overweight in HIV/AIDS persons-treated with antiretroviral therapy

Revista de Nutrição

Luísa Helena Maia Leite²  Ana Beatriz De Mattos Marinho Sampaio¹ 

[1] ,Universidade Federal do Rio de Janeiro Hospital Escola São Francisco de Assis Serviço de Assistência ao Portador de HIV/AIDSRio de Janeiro RJ ,Brasil

关键词: Overweight;    Obesity;    HIV;    Dyslipidemia;    Insulin resistance;    Sobrepeso;    Obesidade;    Dislipidemia;    Resistência à insulina;   

DOI  :  10.1590/S1415-52732008000300002

来源: SciELO

【 摘 要 】

OBJECTIVE: To describe the proportion of overweight among patients with human immunodeficiency virus/Acquired Immune Deficiency Syndrome and correlate overweight and highly active antiretroviral therapy with metabolic complications. METHODS: A cross-sectional study was conducted among human immunodeficiency virus/Acquired Immune Deficiency Syndrome outpatients undergoing nutritional therapy from 2000 to 2006 in a University Health Center. The sample consisted of 393 human immunodeficiency virus/Acquired Immune Deficiency Syndrome patients. Nutritional and medical records were used as a source of data on personal, clinical and biochemical information. Data analysis included descriptive statistics and the Chi-square test. RESULTS: Sixty-nine percent of the patients were males aging from 26 to 49 years. Overweight and obesity were identified in 49% of this population. The most important metabolic complications were low levels of high-density lipoprotein (70%) and high levels of triglycerides (48%) and cholesterol (40%). Higher body mass index was associated with higher lipid levels and more evidence of insulin resistance. CONCLUSION: This study demonstrated an important proportion of overweight and obesity among human immunodeficiency virus/Acquired Immune Deficiency Syndrome patients. These results suggest that nutritional interventions and lifestyle modifications may be useful strategies to decrease the cardiovascular risk in this population.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License